Susceptibility to prostate cancer: Interaction between genotypes at the androgen receptor and prostate-specific antigen loci

Cancer Research

Volumn 60, Issue 4, 2000, Pages 839-841

  Xue, Wenmei ^a   Irvine, Ryan A ^b   Yu, Mimi C ^a   Ross, Ronald K ^a   Coetzee, Gerhard A ^a,b   Ingles, Sue Ann ^a,c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ALLELISM; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DNA POLYMORPHISM; GENE LOCUS; GENE TARGETING; GENETIC ANALYSIS; GENETIC VARIABILITY; HORMONE RESPONSIVE ELEMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; TRANSCRIPTION REGULATION;

AGED; ALLELES; CHROMOSOME MAPPING; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN;

EID: 0034652715     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Ingles, S. A., Ross, R. K., Yu, M. C., Irvine, R. A., La Pera, G., Haile, R. W., and Coetzee, G. A. Association of prostate cancer risk with genetic polymorphism in vitamin D receptor and androgen receptor. J. Natl. Cancer. Inst., 89: 166-170, 1997.
2. Ross, R. K., Pike, M. C., Gerhard, A. C., Reichardt, J. V., Yu, M. C., Feigelson, H., Stanczyk, F. Z., Knolonel, L. N., and Henderson B. E. Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility. Cancer Res., 58: 4497-4504, 1998.
3. Coetzee, G. A., and Ross, R. K. Prostate cancer and the androgen receptor. J. Natl. Cancer Inst., 86: 872-873, 1994.
4. Irvine, R. A., Yu, M. C., Ross, R. K., and Coetzee, G. A. The CAG and GGC microsatellites of androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Res., 55: 1937-1940, 1995.
5. Stanford, J. L., Just, J. J., Gibbs, M., Wichlund, K. G., Neal, C. L., Blumenstein, B. A., and Ostrander, E. A. Polymorphic repeats in the androgen receptor gene: molecular markers for prostate cancer risk. Cancer Res., 57. 1194-1198, 1997.
6. Giovannucci, E., Stampfer, M. J., Krithivas, K., Brown, M., Brufsky, A., Talcott, J., Hennekens, C. H., and Kantoff, P. W. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc. Natl. Acad. Sci. USA, 94: 3320-3323, 1997.
7. Chamberlain, N. C., Driver, E. D., and Miesfeld, R. L. The length and location of CAG trinucleotide repeat in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res., 22. 3181-3186, 1994.
8. n-expanded neuropathies. Hum. Mol. Genet., 4: 523-527, 1995.
9. Rao, A., and Cramer, S. D. Identification of a polymorphism in the ARE I region of the PSA promoter. Proc. Am. Assoc. Cancer Res., 40: 65, 1999.
10. Breslow, N. E., and Day, N. E. Statistical methods in cancer research Vol. 1. Lyon, France: IARC, 1980.
11. Majumdar, S., and Diamandis, E. P. The promoter and the enhancer region of the KLK3 (prostate specific antigen) gene is frequently mutated in breast tumors and in breast carcinoma cell lines. Br. J. Cancer, 79: 1594-1602, 1999.
12. Peehl, D. M. Prostate specific antigen role and function. Cancer (Phila.), 75 (Suppl.): 2021-2026, 1995.
13. Cohen, P., Peehl, D. M., and Rosenfeld, R. G. Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease. J. Endocrinol., 142: 407-415, 1994.
14. Chan, J. M., Stampfer, M. J., and Pollak, M. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science (Washington DC), 279: 563-566, 1998.
15. Cohen, P. Serum insulin-like growth factor-I levels and prostate cancer risk-interpreting the evidence. J. Natl. Cancer Inst., 90: 876-879, 1998.
16. Cramer, S. D., Chen, Z., and Peehl, D. M. Prostate specific antigen cleaves parathyroid hormone-related protein in the PTH-like domain: inactivation of PTHrP-stimulated cAMP accumulation in mouse osteoblasts. J. Urol., 156: 526-531, 1996.
17. Koeneman, K. S., Yeung, F., and Chung, L. K. Osteomimetic properties of prostate cancer cells: a hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment. Prostate, 39: 246-261, 1999.